Neeman Medical International Plc. is an institute for clinical investigation registered in Surrey, United Kingdom with operational headquarters in Raleigh, North Carolina, USA. Neeman Medical International (NMI)'s present areas of operations are in Asia, Latin America, and Europe. NMI commenced its Asian Operations from New Delhi in September 1999.

As second-generation company of Max India Limited, it is promoted by Max Asia Pac Ltd., in concert with Alda Ltd.

Continuing with its global focus, NMI proposes to expand into Panama, Mexico, Argentina, and Poland, Thailand, and South Africa. It anticipates a turnover of US$ 60 million in the next 5 years.